Huaren Pharmaceutical Co Ltd
SZSE:300110
Huaren Pharmaceutical Co Ltd
SZSE:300110
Price:
3.24
CNY
-3.57%
Market Closed
Market Cap:
¥3.8B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Huaren Pharmaceutical Co Ltd
SZSE:300110
|
CN |
|
Zhejiang Qjiang Motorcycle Co Ltd
SZSE:000913
|
CN |
|
Nippon Electric Glass Co Ltd
TSE:5214
|
JP |
|
Whirlpool SA
BOVESPA:WHRL4
|
BR |
|
H
|
Hangzhou Cable Co Ltd
SSE:603618
|
CN |
|
O
|
Origin Enterprises PLC
LSE:OGN
|
IE |
|
Secure Trust Bank PLC
LSE:STB
|
UK |
|
TPG RE Finance Trust Inc
NYSE:TRTX
|
US |
|
Hydro One Ltd
TSX:H
|
CA |
|
M
|
MultiMetaVerse Holdings Limited
NASDAQ:MMV
|
CN |
|
T
|
Toba Surimi Industries Tbk Pt
IDX:CRAB
|
ID |
|
D
|
Deciphera Pharmaceuticals Inc
F:D05
|
US |
|
Blue Water Global Group Inc
OTC:BLUU
|
US |
|
Panthera Resources PLC
LSE:PAT
|
UK |
|
Cofoe Medical Technology Co Ltd
SZSE:301087
|
CN |
|
M
|
Menif Financial Services Ltd
TASE:MNIF
|
IL |
|
V
|
Vanov Holdings Company Ltd
HKEX:2260
|
CN |
|
G
|
Gudou Holdings Ltd
HKEX:8308
|
CN |
|
C
|
Champion Electric Metals Inc
CNSX:LTHM
|
CA |
|
S
|
Singer Thailand PCL
SET:SINGER
|
TH |
|
Nexi SpA
MIL:NEXI
|
IT |
|
N
|
NextSource Materials Inc
OTC:NSRCF
|
CA |
|
G
|
Good Flour Corp
CNSX:GFCO
|
CA |
|
Ipsen SA
PAR:IPN
|
FR |
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Huaren Pharmaceutical Co Ltd's stock price target?
Not Available
Huaren Pharmaceutical Co Ltd doesn't have any price targets made by Wall Street professionals.
What is Huaren Pharmaceutical Co Ltd's Revenue forecast?
Projected CAGR
-2%
-2%
For the last 13 years the
compound annual growth rate for
Huaren Pharmaceutical Co Ltd's revenue is
10%.
The projected
CAGR
for the next 9 years is
-2%.
